Former CDC head pleads guilty in sexual misconduct incident

Amy Baxter | | Health Exec | Management
scales of justice

Thomas Frieden, MD, former director of the CDC, pleaded guilty to a disorderly conduct violation after he was arrested last year for sexual misconduct, the Associated Press reported.

Frieden, who served as director of the CDC from 2009 to 2017, was accused of forcibly grabbing a woman on the buttocks at his home in Brookyln Heights, New York. He was arrested on three charges in August 2018. The incident allegedly took place in October 2017.

While he pleaded guilty in Brooklyn Criminal Court, the violation is not considered a crime, and he does not admit guilt in the groping allegation, the AP reported.

See the full story below:

Former Head of the CDC Pleads Guilty to Violation

Amy Baxter
Amy Baxter

Amy joined TriMed Media as a Senior Writer for HealthExec after covering home care for three years. When not writing about all things healthcare, she fulfills her lifelong dream of becoming a pirate by sailing in regattas and enjoying rum. Fun fact: she sailed 333 miles across Lake Michigan in the Chicago Yacht Club "Race to Mackinac."

Related Content

Q&A: Proposed changes to Social Security Act would recognize pharmacists as healthcare providers
FDA issues Class I recall on counterfeit infusion pump batteries
FDA issues alert on PCNL sheath safety after patient death
Bipartisan bills in Congress would force insurance companies, PBMs to sell pharmacies
Anthem BCBS reverses course on anesthesia time limits
FDA issues Class I recall on insulin syringes due to risk of death

Around the web

Cardiovascular Business
FDA says years-long tirzepatide shortage is resolved, will give limited leeway to compounders

The tirzepatide shortage that first began in 2022 has been resolved. Drug companies distributing compounded versions of the popular drug now have two to three more months to distribute their remaining supply.

AI in Healthcare
From Capitol Hill to a hospital near you? 5 federal recommendations for healthcare AI policy

The 24 members of the House Task Force on AI—12 reps from each party—have posted a 253-page report detailing their bipartisan vision for encouraging innovation while minimizing risks. 

Cardiovascular Business
Merck spends up to $2B to license new weight loss drug with potential heart benefits

Merck sent Hansoh Pharma, a Chinese biopharmaceutical company, an upfront payment of $112 million to license a new investigational GLP-1 receptor agonist. There could be many more payments to come if certain milestones are met.